OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
63
Results
Show all
Save search
Copy query
Show results for
Unknown
(63)
Publication Date
Release Date
2021
(15)
2022
(12)
2023
(8)
2024
(7)
2025
(6)
2012
(3)
2020
(2)
2019
(2)
2018
(2)
2014
(2)
2011
(2)
2015
(1)
2013
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
The genome of the zoonotic malaria parasite Plasmodium simium reveals adaptations to host switching.
Not available
S-EPMC8485552
|
biostudies-literature
Cite
Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.
Not available
S-EPMC4673902
|
biostudies-literature
Cite
A genome-informed higher rank classification of the biotechnologically important fungal subphylum
Saccharomycotina
.
Not available
S-EPMC11182611
|
biostudies-literature
Cite
Tracking Five Millennia of Horse Management with Extensive Ancient Genome Time Series.
Not available
S-EPMC6547883
|
biostudies-literature
Cite
Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG.
Not available
S-EPMC8282734
|
biostudies-literature
Cite
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
Not available
S-EPMC7614690
|
biostudies-literature
Cite
Hebb's Vision: The Structural Underpinnings of Hebbian Assemblies.
Not available
S-EPMC12258723
|
biostudies-literature
Cite
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
Not available
S-EPMC9630157
|
biostudies-literature
Cite
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
Not available
S-EPMC9646993
|
biostudies-literature
Cite
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Not available
S-EPMC7616346
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets